ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag short bowel syndrome genetics genomics ecology neuroscience

bacteria and DNA molecules on a purple background.
Engineering the Microbiome: CRISPR Leads the Way
Mariella Bodemeier Loayza Careaga, PhD | Mar 15, 2024 | 10+ min read
Scientists have genetically modified isolated microbes for decades. Now, using CRISPR, they intend to target entire microbiomes.
How Well Do Mice Model Humans?
Ricki Lewis | Oct 25, 1998 | 8 min read
STRIKING RESEMBLANCE: James Croom, who studies Down syndrome mice at North Carolina State University, says the animals are providing valuable information useful to humans. When a page-one article in the May 3, 1998, Sunday New York Times portrayed angiogenesis inhibitors that fight cancer in mice as being possible just around the corner for humans, criticism for raising false hopes erupted. Merely 10 weeks later, however, when researchers from the University of Hawaii reported cloning the fi
Alternative Medicines
The Scientist | Jul 1, 2012 | 10+ min read
As nonconventional medical treatments become increasingly mainstream, we take a look at the science behind some of the most popular.
The Urge to Merge
Arielle Emmett | Apr 2, 2000 | 10+ min read
Graphic: Cathleen Heard SmithKline Beecham and Glaxo Wellcome; Pfizer and Warner-Lambert; Pharmacia & Upjohn and Monsanto; PE Biosystems and Third Wave; Astra and Zeneca. In the last year, many top-tier biotech and pharmaceutical giants have reached definitive agreements to merge. The unions are touted as hostile or friendly, strategic or tactical, market driven, Machiavellian, culturally astute, even desperate. Competition has forced drug companies to up the ante for blockbuster development

Run a Search

ADVERTISEMENT